Predictive Value of Quantitative Parameters in Evaluating Radiotherapy Efficacy for Hepatocellular Carcinoma Based on IQon Spectral CT: A Prospective Study
Abstract
Background: Currently, there is a lack of reliable biomarkers for the early prediction of therapeutic response to radiotherapy in patients with hepatocellular carcinoma (HCC).Conventional imaging modalities are limited in their ability to detect early treatment-induced changes.IQon Spectral computed tomography (CT), as an advanced imaging technique, enables the acquisition of quantitative parameters, including iodine concentration and spectral curve slope, thereby providing a novel, noninvasive method for assessing tumor angiogenesis and metabolic activity.This study aims to prospectively evaluate the clinical utility of these quantitative parameters in predicting radiotherapy outcomes in HCC.Method: This prospective study enrolled 30 patients with HCC who met the predefined inclusion and exclusion criteria were prospectively enrolled between July 2022 and June 2024.All patients received two cycles of radiotherapy and underwent IQon Spectral CT scans both before and after treatment.Based on the modified Response Evaluation Criteria in Solid Tumors (mRECIST), patients were classified into an effective group (complete response [CR] + partial response [PR]) and an ineffective group (stable disease [SD] + progressive disease [PD]).Changes in CT-derived quantitative parameters before and after radiotherapy were compared and analyzed, a predictive model for therapeutic efficacy was constructed, and receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic performance.Results: All 30 patients were diagnosed with HCC at clinical stages II-IV.Among them, 3 achieved CR, 19 achieved PR, 5 had SD, and 3 had PD.To evaluate the therapeutic efficacy of radiotherapy in HCC, three parameters-spectral curve slope (KAP), iodine content (ICAP), and normalized iodine concentration (NICAP)-were integrated during the arterial phase before treatment.Based on these parameters, five prediction models were constructed: bivariate models, a trivariate model, and a joint prediction model.The area under the curve (AUC) values were as follows: KAP_ICAP model, 0.642 (95% CI: 0.410-0.874);KAP_NICAP model, 0.886 (95% CI: 0.759-1); ICAP_NICAP model, 0.898 (95% CI: 0.778-1); and KAP_ICAP_NICAP trivariate model, 0.915 (95% CI: 0.814-1), with a sensitivity of 86.4% and specificity of 87.5%.DeLong test results indicated that the predictive performance of the KAP_ICAP_ NICAP model was significantly superior to that of the KAP_ICAP model (Z = -2.396,P = 0.017), but no statistically significant differences were observed when compared with other bivariate models (P>0.05).The joint prediction model also achieved an AUC of 0.915 (95% CI: 0.810-1), with a sensitivity of 90.9%, specificity of 87.5%, positive predictive value
Fields of Study & Subjects
Hepatocellular Carcinoma Treatment and Prognosis
Medical Imaging Techniques and Applications
Radiomics and Machine Learning in Medical Imaging
Publication details
- Journal / source
- Journal of Radiology and Clinical Imaging
- Volume
- 9
- Issue
- 1
- Publication date
- 1 January 2026
- Language
- EN